The Golden Riddle: New Gold's Q3 Figures and the Market's Uneasy Dance
Abbott Labs Faces Mixed Fortunes in Q3: Revenue Missed, But Earnings & Future Outlook Impress
Cosciens Biopharma's Q1 Unveils Growth Amidst Wider Losses